Drug profile · INN
budesonide + glycopyrronium + formoterol
BREZTRI AEROSPHERE
budesonide + glycopyrronium + formoterol (BREZTRI AEROSPHERE) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — budesonide + glycopyrronium + formoterol
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
budesonide + glycopyrronium + formoterol (BREZTRI AEROSPHERE) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is budesonide + glycopyrronium + formoterol?
budesonide + glycopyrronium + formoterol (BREZTRI AEROSPHERE) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca.
What is the brand name for budesonide + glycopyrronium + formoterol?
BREZTRI AEROSPHERE is a marketed brand name for budesonide + glycopyrronium + formoterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.